您的位置：
首页
>
农业专利
>
详情页
(Thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity H1 inverse agonists/5-HT2A antagonists
- 专利权人:
- Eli Lilly and Company
- 发明人:
- Peter Thaddeus Gallagher
- 申请号：
- US14758023
- 公开号：
- US09562057B2
- 申请日:
- 2014.01.08
- 申请国别(地区):
- US
- 年份:
- 2017
- 代理人:
- 摘要：
- A dual H1 inverse agonist/5-HT2A receptor antagonist of the formula:its uses, and methods for its preparation are described.
- 来源网站：
- 中国工程科技知识中心
- 来源网址：
- http://www.ckcest.cn/home/
相关专利
- (THIENO[2,3-B][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
- (thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity H1 inverse agonists/5-HT2A antagonists
- (THIENO[2,3-B][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
- (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
- (THIENO(2,3-b)(1,5)BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
